Sickle Cell Disease: Genetics, Pathophysiology, and Clinical Aspects

Sickle Cell Disease: Genetics, Pathophysiology, and Clinical Aspects

Introduction

Sickle cell disease (SCD) is a well-studied genetic disorder that affects the structure and function of hemoglobin in red blood cells. This set of notes covers the genetic basis, molecular mechanisms, clinical features, and historical context of SCD, as well as the protective role of fetal hemoglobin.

Hemoglobinopathies

Overview of Hemoglobinopathies

• Hemoglobinopathies are among the most common genetic diseases worldwide.

• Approximately 5% of the global population carries genes for clinically significant hemoglobin (Hb) disorders.

• Each year, about 300,000 severely affected homozygotes or compound heterozygotes are born.

• Caused by:

  • Production of structurally abnormal hemoglobin molecules

  • Synthesis of insufficient quantities of normal hemoglobin

  • Rarely, both mechanisms

Types of Hemoglobinopathies

• Structural Variants: Altered globin peptide sequence without affecting the rate of synthesis (usually single base changes).

• Thalassemias: Decreased synthesis of one or more globin chains, leading to an imbalance in the relative amounts of the α and β chains.

• Hereditary Persistence of Fetal Hemoglobin (HPFH): Continued production of fetal hemoglobin into adulthood.

Sickle Cell Disease (SCD)

Definition and Inheritance

• Sickle cell disease is an autosomal recessive inherited blood disorder.

• It primarily affects red blood cells, which contain mostly hemoglobin S (HbS), an abnormal type of hemoglobin.

Historical Context

• The first description of SCD was in 1904, involving a 20-year-old patient, Walter Clement Noel, whose blood cells were described as "having the shape of a sickle." This was observed by Dr. Ernest Irons and published by Dr. James Herrick.

• Early observations noted that sickling was seen only in blood of Black individuals.

Microscopic Appearance

• Red blood cells in SCD patients often appear crescent or sickle-shaped under the microscope, in contrast to the normal round, biconcave shape.

Relationship to Oxygen

• In 1927, Hahn and Gillespie demonstrated that sickling of red blood cells is related to low oxygen levels.

• In 1940, Sherman observed that deoxygenated red cells showed birefringence, suggesting that low oxygen alters the hemoglobin structure.

Protective Role of Fetal Hemoglobin (HbF)

• Janet Watson (1948) published findings that fetal hemoglobin (HbF) reduces the clinical severity of SCD.

• Newborns with SCD have fewer sickled cells due to the presence of HbF, which does not sickle like adult hemoglobin S.

Key Terms and Concepts

• Hemoglobin (Hb): The oxygen-carrying protein in red blood cells, composed of two alpha and two beta globin chains.

• Hemoglobin S (HbS): The abnormal hemoglobin variant responsible for SCD, resulting from a single amino acid substitution in the β-globin chain.

• Autosomal Recessive Inheritance: Both copies of the gene (one from each parent) must be mutated for the disease to manifest.

• Fetal Hemoglobin (HbF): The primary hemoglobin in the fetus, composed of two alpha and two gamma chains; persists in small amounts after birth.

Summary Table: Types of Hemoglobinopathies

Type	Genetic Basis	Main Effect	Example
Structural Variant	Point mutation in globin gene	Abnormal hemoglobin structure	Sickle Cell Disease (HbS)
Thalassemia	Deletion or mutation in globin gene	Reduced synthesis of globin chains	β-thalassemia, α-thalassemia
HPFH	Mutation in regulatory regions	Continued HbF production	Hereditary Persistence of Fetal Hemoglobin

Inheritance Pattern of Sickle Cell Disease

• SCD is inherited in an autosomal recessive manner.

• Both parents must be carriers (heterozygous for the HbS allele) for a child to be affected.

• Carrier state (sickle cell trait) usually does not cause symptoms.

Clinical Relevance

• SCD is a major cause of morbidity and mortality in affected populations.

• Understanding the genetic and molecular basis of SCD is essential for diagnosis, management, and development of new therapies.

Example: Sickle Cell Trait vs. Sickle Cell Disease

• Sickle Cell Trait (heterozygous): One normal β-globin gene and one HbS gene; usually asymptomatic.

• Sickle Cell Disease (homozygous): Two HbS genes; leads to chronic hemolytic anemia and vaso-occlusive crises.